External quality assessment for tuberculosis diagnosis and drug resistance in the European union: A five year multicentre implementation study

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Nikolayevskyy, Vladyslav ^a,d   Hillemann, Doris ^b   Richter, Elvira ^b   Ahmed, Nada ^a   Van Der Werf, Marieke J ^c   Kodmon, Csaba ^c   Drobniewski, Francis ^a,d   Ruesch Gerdes, Sabine ^b  

^a HPA National Mycobacterium Reference Laboratory   (United Kingdom)

^b RESEARCH CENTER BORSTEL   (Germany)

^c EUROPEAN CENTRE FOR DISEASE PREVENTION AND CONTROL ECDC   (Sweden)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CAPREOMYCIN; ETHAMBUTOL; PYRAZINAMIDE; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; ATYPICAL MYCOBACTERIUM; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CONTROLLED STUDY; MICROSCOPY; MYCOBACTERIUM ABSCESSUS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM CAPRAE; MYCOBACTERIUM CELATUM; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM FORTUITUM; MYCOBACTERIUM GORDONAE; MYCOBACTERIUM INTRACELLULARE; MYCOBACTERIUM KANSASII; MYCOBACTERIUM MALMOENSE; MYCOBACTERIUM MARINUM; MYCOBACTERIUM SIMIAE; MYCOBACTERIUM SZULGAI; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; QUALITY CONTROL; TUBERCULOSIS; CLINICAL TRIAL; EUROPEAN UNION; HUMAN; LABORATORY TECHNIQUE; MULTICENTER STUDY;

ANTITUBERCULAR AGENTS; CLINICAL LABORATORY TECHNIQUES; DRUG RESISTANCE, BACTERIAL; EUROPEAN UNION; HUMANS; TUBERCULOSIS;

EID: 84963623732     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0152926     Document Type: Article

References (20)

1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2015. Stockholm: European Centre for Disease Prevention and Control, 2015.
2. Lonnroth K, Migliori GB, Abubakar I, D'Ambrosio L, de Vries G, et al. (2015) Towards tuberculosis elimination: An action framework for low-incidence countries. Eur Respir J 45: 928-952. doi:10.1183/09031936.00214014 PMID: 25792630.
3. Drobniewski FA, Nikolayevskyy V, Hoffner S, Pogoryelova O, Manissero D, et al. (2008) The added value of a European Union tuberculosis reference laboratory network-analysis of the national reference laboratory activities. Euro Surveill 13.
4. Drobniewski F, Nikolayevskyy V, Maxeiner H, Balabanova Y, Casali N, Konsevaya I, Ignatyeva O (2013) Rapid Diagnostics of Tuberculosis and Drug Resistance in the Industrialized World: Clinical and Public Health Benefits and Barriers to Implementation. BMC Medicine in press.
5. Drobniewski F, Nikolayevskyy V, Balabanova Y, Bang D, Papaventsis D (2012) Diagnosis of tuberculosis and drug resistance: What can new tools bring us? Int J Tuberc Lung Dis 16: 860-870. doi:10.5588/ijtld.12.0180 PMID: 22687497.
6. Kato-Maeda M, Metcalfe JZ, Flores L (2011) Genotyping of Mycobacterium tuberculosis: Application in epidemiologic studies. Future Microbiol 6: 203-216. doi:10.2217/fmb.10.165 PMID: 21366420.
7. Niemann S, Supply P (2014) Diversity and evolution of Mycobacterium tuberculosis: moving to wholegenome- based approaches. Cold Spring Harb Perspect Med 4: A021188. doi:10.1101/cshperspect.a021188 PMID: 25190252.
8. ISO 15189:2012. Medical laboratories-Requirements for quality and competence. International Standard Organization 2012.
9. Drobniewski FA, Hoffner S, Rusch-Gerdes S, Skenders G, Thomsen V (2006) Recommended standards for modern tuberculosis laboratory services in Europe. Eur Respir J.
10. Drobniewski FA, Watt B, Smith EG, Magee JG, Williams R, et al. (1999) A national audit of the laboratory diagnosis of tuberculosis and other mycobacterial diseases within the United Kingdom. J Clin Pathol 52: 334-337. PMID: 10560351.
11. Walton C, Hawkey PM, James VL (2005) Examination of specimens for mycobacteria in clinical laboratories in 21 countries: A 10-year review of the UK National Quality Assessment Scheme for Mycobacteria Culture. Clin Microbiol Infect 11: 1016-1021. PMID: 16307557.
12. Fattorini L, Iona E, Cirillo D, Migliori GB, Orefici G, et al. (2008) External quality control of Mycobacterium tuberculosis drug susceptibility testing: Results of two rounds in endemic countries. Int J Tuberc Lung Dis 12: 214-217. PMID: 18230256.
13. de Beer JL, Kodmon C, van Ingen J, Supply P, van Soolingen D, et al. (2014) Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex. Int J Tuberc Lung Dis 18: 594-600. doi:10.5588/ijtld.13.0531 PMID: 24903798.
14. de Beer JL, Kremer K, Kodmon C, Supply P, van Soolingen D, et al. (2012) First worldwide proficiency study on variable-number tandem-repeat typing of Mycobacterium tuberculosis complex strains. J Clin Microbiol 50: 662-669. doi:10.1128/JCM.00607-11PMID: 22170917.
15. Hillemann D, Hoffner S, Cirillo D, Drobniewski F, Richter E, et al. (2013) First Evaluation after Implementation of a Quality Control System for the Second Line Drug Susceptibility Testing of Mycobacterium tuberculosis Joint Efforts in Low and High Incidence Countries. PLoS One 8: E76765. doi:10.1371/journal.pone.0076765 PMID: 24146924.
16. European Centre for Disease Prevention and Control. Framework Action Plan to Fight Tuberculosis. 2008. Available at: http://ecdc.europa.eu/en/publications/publications/0803-spr-tb-action-plan.pdf.
17. Brown TJ, Herrera Leon L, Anthony RM, Drobniewski FA (2006) The use of macroarrays for the identification of MDR Mycobacterium tuberculosis. J Microbiol Methods 65: 294-300. PMID: 16153726.
18. Johansen IS, Larsen AR, Sandven P, Petrini B, Soini H, et al. (2003) Drug susceptibility testing of Mycobacterium tuberculosis to fluoroquinolones: first experience with a quality control panel in the Nordic- Baltic collaboration. Int J Tuberc Lung Dis 7: 899-902. PMID: 12971676.
19. Laszlo A, Rahman M, Espinal M, Raviglione M (2002) Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference LaboratoryNetwork: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 6: 748-756. PMID: 12234129.
20. Shulgina MV, Malakhov VN, Hoffner SE, Haile M, Wright A (2009) Results of the external quality assessment of Mycobacterium tuberculosis drug susceptibility testing in Russia, 2005-2007. Int J Tuberc Lung Dis 13: 1294-1300. PMID: 19793436.